Patel C, Pasciolla M, Abramova R, Salerno D, Arteaga AGomez, Shore TB, Orafali N, Mayer S, Hsu J, Phillips AA, et al. Pre-hematopoietic stem cell transplant rituximab for Epstein-Barr Virus and post-transplant lymphoproliferative disorder prophylaxis in alemtuzumab recipients. Transplant Cell Ther. 2022.